FDA QS reg/CLIA Comparison: Overview

Slides:



Advertisements
Similar presentations
Elizabeth Mansfield, PhD OIVD Public meeting July 19, 2010
Advertisements

CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
1 Testing in the Open Market Testing in the Open Market AAAS Colloquium on Personalized Medicine: Planning for the Future June 2, 2009 Courtney C. Harper,
PRINCIPLES OF A CALIBRATION MANAGEMENT SYSTEM
Regulatory Pathway for Platform Technologies
QUALITY CONTROL IN HEMATOLOGY
1 FDA/CDRH PUBLIC MEETING; Blood Glucose Meters FDA/CDRH PUBLIC MEETING; Blood Glucose Meters FDA Perspective: Regulatory Challenges for Safe use of Blood.
Coping with Electronic Records Setting Standards for Private Sector E-records Retention.
Laboratory Accumulation of Hazardous Waste Presented By: Richard Smith Environmental Health & Safety Administrative Office Research and Extension Centers.
Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.
Standar-standar yang melibatkan radiologi
Laboratory Management - 1
21 CFR PART 11 REGULATIONS RECOMMENDATIONS FOR CHANGES FDA PUBLIC MEETING ON PART 11 REGULATIONS – JUNE 11, 2004 NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION.
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
Radiological Devices Advisory Committee Meeting November 18, 2009 John A. DeLucia iCAD, Inc.
QUALITY ASSURANCE Shree Baboolal 12 th February, 2005.
CLIA COMPLIANCE. What is CLIA? In 1988 Congress turned its attention to deficiencies in the quality of services provided by the nation’s laboratories.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
FDA Regulation of In Vitro Diagnostic Tests FDA Regulation of In Vitro Diagnostic Tests George Washington University March 8, 2011 Katherine Serrano Office.
by Joint Commission International (JCI)
Introduction to ISO New and modified requirements.
VALIDATION METHODOLOGY
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
Performance Improvement in Microbiology Laboratory
Cap.org v. FNL FDA: Challenges to Protecting Public Health – Pathology’s Perspective Roger D. Klein, M.D., JD, F.C.A.P. March 7, 2013 Advocacy.
Module 4 Assuring the Quality of Testing: A Systems Approach to Quality (ISO 15189:2012) Assuring the Quality of Laboratory Testing: A Systems Approach.
Module 5: Assuring the Quality of HIV Rapid Testing
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
1 FDA/CDRH Office of In Vitro Diagnostic Devices The Pre-IDE Process Sousan S. Altaie, Ph.D. Scientific Policy Advisor OIVD.
FSC402H FORENSIC SCIENCE AND THE EXPERT December 2, 2003.
IN THE NAME OF GOD Quality Assurance and Blood Bank S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO)
FDA’s Draft LDT Framework & Personalized Medicine Update
Important informations
Lesson 8 Good Production Practice #8 Follow appropriate on-farm feed and commercial feed processor procedures.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Introduction to the Clinical Laboratory
Saftey Agencies in Healthcare Practice OSHA CDCP CLIA FDA ISO WHO NIH USDHHS.
Who makes up all these rules?? A discussion on Regulatory Agencies and how they relate to each other and our lab.
Dispensary and Administration Site Information Presentation.
Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
Quality control & Statistics. Definition: it is the science of gathering, analyzing, interpreting and representing data. Example: introduction a new test.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
Laboratory Field Services Regulations 2015
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
ESSENTIAL MANAGEMENT PACKAGE For Physical Rehabilitation Centers Kate Wilson, Technical Advisor, LMG November, 2014.
Awareness Training: ‘HARPC’ for Food Safety Complimentary Presentation by Quality Systems Enhancement 1790 Wood Stock Road Roswell GA E. mail:
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
HuQAS Proficiency testing Scheme - A necessity in continuous quality improvement Michael Kamiru
Introduction to Quality Assurance. Quality assurance vs. Quality control.
Lesson 1-9 Quality Assessment.
Quality Control and Assurance
QUALITY MANAGEMENT Suzanne Kamel-Mohamed PhD, MBA, MT (ASCP) Associate
Overview of Quality Assurance
FDA Perspective on Cardiovascular Device Development
Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
Overview of vaccines prequalification
Quality Systems in a Production Facility
Background and Rationale for the development of the Primary Health Care (PHC) Laboratory Toolkit
FOOD AND VETERINARY OFFICE
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
World Health Organization
Medication Management Policy & Procedure
Safety and Regulatory Guidelines In the Medical Laboratory
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Research Operations and Lab Services
Presentation transcript:

FDA QS reg/CLIA Comparison: Overview Open Meeting on the Oversight of LDTs November 22, 2010 Katherine Serrano Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health/FDA Katherine.serrano@fda.hhs.gov

FDA Quality System Regulation (QS reg): Overview Purpose: To ensure that medical devices consistently meet applicable requirements and specifications and are generally safe and effective for their intended use General Overview: Regulation includes requirements related to methods used in and the facilities and controls for: Designing Purchasing Manufacturing Packaging Labeling Storing Installing Servicing Flexibility of the QS reg: Must apply to many types of devices; different types of manufacturers Not written in a “prescriptive manner”

Clinical Laboratory Improvement Amendments (CLIA): Overview Impetus: Inaccurately read Pap Smears Objective: Establish quality standards for laboratory testing to ensure the accuracy, reliability, and timeliness of patient test results Overview: Labs must enroll and meet all major CLIA quality requirements Personnel Proficiency Testing (PT) Quality Control (Analytic Systems) Patient Test Management (Pre-Analytic and Post-Analytic Systems) Facility Administration Quality Assessment

FDA QS reg/CLIA Comparison FDA/CMS Collaboration to analyze and compare the FDA QS reg and CLIA requirements Summary of the analysis: No conflicting requirements Many CLIA requirements may partially fulfill FDA QS reg requirements Examples: Administrative, personnel, record keeping/storage requirements, etc. Many CLIA requirements are analogous to FDA QS reg requirements Examples: Identification, handling requirements to prevent mix-ups, etc.

FDA QS reg/CLIA Comparison: Summary of the analysis (continued): There are some cases where CLIA requirements do not address some elements of the FDA QS reg requirements Quality requirements for the test development process are a focus of the FDA FDA focus on use of appropriate statistical techniques for sampling plans, validation studies etc.

FDA QS reg/CLIA Comparison: Conclusions Many elements of CLIA already address several requirements of the FDA QS reg Processes and procedures implemented to meet the FDA QS reg will not hinder Labs’ ability to meet CLIA requirements

Thanks! Katherine.serrano@fda.hhs.gov